Jan Tosovsky

Jan Tosovsky

Auto-generated profile, based on publicly available information

Jan Tosovsky

Clinic of Cardiovascular Surgery

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
VRVilém Rohn
Vilém Rohn
MŠMiroslav Špaček
Miroslav Špaček
JBJan Belohlavek
Jan Belohlavek
JTJan Tosovsky
Jan Tosovsky
We present the case of a 62-year-old female patient admitted to our center for cardiogenic shock due to large inferior myocardial infarct. Echocardiography revealed dysfunction of left ventricle, dilation of right ventricle, mitral valve insufficiency, and a large posterior ventricular septal defect (VSD). Coronary angiography showed occlusion of the right coronary artery. An attempt of percutaneous coronary intervention (PCI) of right coronary and posterior descending artery was not successful due to old thrombi. Despite inotropes and intraaortic balloon pump (IABP) there was severe hemodynamic instability. Therefore, we commenced veno-arterial extracorporeal membrane oxygenation (ECMO) as a ventricular assist device (VAD). Immediately we obtained the stabilization of the patient and the improvement of the clinical conditions. The third day after implantation, the closure of the defect, mitral valve plasty, and bypass to posterior descending artery were performed. The patient was discharged from the hospital 59 days after the operation. Six months after the operation, the patient was in good condition.


1 September 2009 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
TGT. Grus
T. Grus
JLJarosla Lindner
Jarosla Lindner
TVT. Vidim
T. Vidim
JTJ. Tosovsky
J. Tosovsky
JMJ. Matecha
J. Matecha
GGG. Grusova
G. Grusova

6 December 2006 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
JLJarosla Lindner
Jarosla Lindner
PJPavel Jansa
Pavel Jansa
JKJ. Kunstyr
J. Kunstyr
EME. Mayer
E. Mayer
JBJ. Blaha
J. Blaha
IVI. Vitkova
I. Vitkova
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) in indicated cases can be successfully cured by endartectomy of pulmonary arteries (PEA). Symptomatic nontreated CTEPH has a very poor prognosis; the five-year survival rate in patients with a medium pressure of over 50 mmHg in the main pulmonary artery is as low as 10 %. This kind of operation was previously not available in the Czech Republic. In 2004, a PEA programme was launched at the Cardiocentre of the General Teaching Hospital in Prague in co-operation with the institution of a well known specialist in this field (Prof. Mayer, Johannes Gutenberg University in Mainz, Germany). Patients: Between September 2004 and January 2006, 21 patients (14 males and 7 females; average age 48 years) with CTEPH were operated on, after a complex investigation. The mean pressure in the main pulmonary artery in these patients was 54.8 mmHg; 7 patients suffered from coagulopathy. Method: The new surgical technique, modifications of which are used at most facilities, was developed by Jamieson and Daily at the University of California in San Diego: an arrest of circulation in deep hypothermia to protect the brain is vital for the visualisation of distal branches of the pulmonary artery. Results: 21 patients were operated on with a mortality of 4.76 % (1 patient died). Other surgeries performed were suture of a defect of the atrial septum (three times), aortocoronary bypass (three times), and cryoablation of the right atrium for flutter (once). The average circulatory arrest time was 42 minutes, the average total pumping time was 331 minutes, and the average total duration of an operation was 450 minutes; the average duration of mechanical ventilation was 58 hours. Within one month there was a considerable improvement or normalisation of haemodynamic parameters and an increase in the average walking distance on the six-minute walking test by 132 metres. Conclusions: PEA is a curative method for patients with CTEPH with a surgically accessible obstruction of the pulmonary artery. Centralisation of the care of these patients is a rational necessity, as this enables the centre to gain a maximum of experience with this complicated diagnosis and treatment. Multidisciplinary co-operation is a sine qua non for success in these programmes.

1 June 2011
Verified
Journal Article
Closed access
JBJ Belohlávek
J Belohlávek
VRV Rohn
V Rohn
JTJan Tosovsky
Jan Tosovsky
JKJan Kunstyr
Jan Kunstyr
MSM Semrád
M Semrád
JLJarosla Lindner
Jarosla Lindner

1 January 2000 in Acta Medica (Hradec Kralove, Czech Republic)
Verified
Journal Article
Open access
PDF file
RBRadim Brát
Radim Brát
JTJan Tošovský
Jan Tošovský
JJJaroslav Januška
Jaroslav Januška
LDLeo Derych
Leo Derych
SVSvatopluk Velkoborský
Svatopluk Velkoborský
JDJan Dominik
Jan Dominik
This study was done to compare the protective effect of blood and crystalloid cardioplegia in patients with left ventricular dysfunction undergoing coronary artery bypass grafting (CABG). Sixty consecutive patients with left ventricular ejection fraction < 35 % scheduled for CABG with the use of cardiopulmonary bypass without additional procedures were randomly divided into two groups. In the first group we used cold blood cardioplegia, in the second group cold crystalloid cardioplegia, both delivered only ortogradly. We measured hemodynamic data in early hours after operation, enzyme release and we collected other clinical data which could be influenced by perioperative myocardial protection. There was no death in either group. We also didn’t find any significant difference in incidence of perioperative myocardial infarction, arrhytmias and use of intraaortic balloon pumping between both groups. In an early hours after operation in the group with blood cardioplegia we found significantly better hemodynamic data (LVSWI, RVSWI) and significantly lower enzyme release. We conclude, that cold blood cardioplegia shows superior perioperative myocardial protection resulting in earlier restoration of myocardial function. This difference could be important in patients with high degree of left ventricular dysfunction.